{
    "nctId": "NCT05951699",
    "briefTitle": "Mini-invasive Detection of Residual Disease in Breast Cancer Patients in Remission After Primary Chemotherapy",
    "officialTitle": "Prospective Clinical Trial to Assess a Mini-invasive Pre-surgical Procedure to Detect Residual Breast or Axillary Disease in Patients With cT1-T2-T3 cN0/N1 Breast Cancer in Complete Clinical/Radiological Remission After Primary Chemotherapy",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 105,
    "primaryOutcomeMeasure": "Evaluation of the accuracy of histological examination of the breast VAB performed pre-surgery",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Radiologically confirmed unifocal cT1-cT2-cT3 cN0-cN1 breast cancer patients indicated for primary chemotherapy\n* Histologically confirmed HER2-positive, triple negative or luminal B HER2-positive invasive breast cancer\n* Clinical/radiological complete response or residual breast disease \\<1 cm after primary chemotherapy\n* Absence of locoregional relapse or distant metastasis\n* Signed informed consent to participate.\n\nExclusion Criteria:\n\n* Disease surgically inoperable or surgery not performed\n* Multifocal disease or presence of microcalcifications at imaging.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}